In recent years, studies have shown that bone
is an endocrine organ and produces hormones that affect brain
development, glucose balance, kidney function, and male fertility.
A hormone secreted by bone cells can suppress appetite, according to
mouse studies conducted by Columbia University Medical Center (CUMC)
researchers.
Eating Fruits and Vegetables Linked to Weight Loss
Eat more and lose weight? Yes! Eating more fruits that are rich in flavonoids, is the new mantra that could help you to lose weight in the long run.
Advertisement
‘The bone hormone - called lipocalin 2 - turns on neurons in the brain that have been previously linked to appetite suppression.’
Tweet it Now
The hormone - called lipocalin 2 - turns on neurons in the brain that have been previously linked to appetite suppression. The findings reveal a previously unknown mechanism for regulating the body's energy balance and could lead to new targeted therapies for the treatment of obesity, type 2 diabetes, and other metabolic disorders.
The study was published online today in the journal Nature.
Study leader Stavroula Kousteni, associate professor of physiology and cellular biophysics (in medicine) at CUMC, said, "Our findings add a critical new function of bone hormones to this list - appetite suppression - which may open a wholly new approach to the treatment of metabolic disorders."
![Political Leaning, Weight Shape Opinions on Fighting Obesity]( "Political Leaning, Weight Shape Opinions on Fighting Obesity")
People's political leanings and their own weight shape opinions on obesity-related public policies.
In 2007, a CUMC team led by Gerard Karsenty, the Paul A. Marks Professor of Genetics and Development and professor of medicine, and chair, Department of Genetics and Development at CUMC, was the first to discover that bone is an endocrine organ that regulates energy metabolism through the release of a hormone called osteocalcin. "We hypothesized that there were additional bone hormones that regulate metabolism, since other endocrine organs that affect metabolism usually do so through multiple hormones," said Dr. Kousteni.
The first clues to a second hormone came in 2010, when Dr. Kousteni discovered that disabling a gene called FOXO1 in mouse osteoblasts (bone-forming cells) caused the mice to eat less and improved their glucose balance. "Since osteocalcin does not regulate appetite, we knew that a second bone hormone had to be involved in this process," said Dr. Kousteni.
In the current study, the CUMC researchers demonstrated that FOXO1-deficient osteoblasts express unusually high amounts of a protein called lipocalin 2. Lipocalin 2 was previously thought to be primarily secreted by adipocytes (fat cells) and to contribute to obesity. But the researchers showed, using mice that could not produce lipocalin in either their fat cells or osteoblasts, that lipocalin 2 is primarily secreted by osteoblasts and reduces appetite and weight.
Lipocalin 2 also affected appetite and weight in normal-weight mice and in mice that were obese due to a lack of the leptin receptor and leptin signalling. In both types of mice, lipocalin 2 suppressed appetite, improved overall metabolism, and reduced body weight.
Dr. Kousteni and her team also found that lipocalin 2 crosses the blood-brain barrier. In the brain, the protein binds to and activates melanocortin 4 receptor (MC4R) neurons in the hypothalamus, the primary brain region that regulates appetite. MC4R neurons are known to be involved in triggering appetite suppression.
"The hope is that lipocalin 2 might have the same effects in humans, and that our findings can be translated into the development of therapies for obesity and other metabolic disorders," said Dr. Kousteni.
Initial findings in humans are encouraging. In an analysis of patients with type 2 diabetes, the researchers found that blood levels of lipocalin 2 were inversely correlated with body weight and blood A1c levels, a long-term measure of blood sugar. "In other words, patients with higher lipocalin 2 levels had lower body weight and better glucose balance," said Dr. Kousteni.
Source: Eurekalert
Study leader Stavroula Kousteni, associate professor of physiology and cellular biophysics (in medicine) at CUMC, said, "Our findings add a critical new function of bone hormones to this list - appetite suppression - which may open a wholly new approach to the treatment of metabolic disorders."
Political Leaning, Weight Shape Opinions on Fighting Obesity
People's political leanings and their own weight shape opinions on obesity-related public policies.
Advertisement
In 2007, a CUMC team led by Gerard Karsenty, the Paul A. Marks Professor of Genetics and Development and professor of medicine, and chair, Department of Genetics and Development at CUMC, was the first to discover that bone is an endocrine organ that regulates energy metabolism through the release of a hormone called osteocalcin. "We hypothesized that there were additional bone hormones that regulate metabolism, since other endocrine organs that affect metabolism usually do so through multiple hormones," said Dr. Kousteni.
The first clues to a second hormone came in 2010, when Dr. Kousteni discovered that disabling a gene called FOXO1 in mouse osteoblasts (bone-forming cells) caused the mice to eat less and improved their glucose balance. "Since osteocalcin does not regulate appetite, we knew that a second bone hormone had to be involved in this process," said Dr. Kousteni.
In the current study, the CUMC researchers demonstrated that FOXO1-deficient osteoblasts express unusually high amounts of a protein called lipocalin 2. Lipocalin 2 was previously thought to be primarily secreted by adipocytes (fat cells) and to contribute to obesity. But the researchers showed, using mice that could not produce lipocalin in either their fat cells or osteoblasts, that lipocalin 2 is primarily secreted by osteoblasts and reduces appetite and weight.
Lipocalin 2 also affected appetite and weight in normal-weight mice and in mice that were obese due to a lack of the leptin receptor and leptin signalling. In both types of mice, lipocalin 2 suppressed appetite, improved overall metabolism, and reduced body weight.
Dr. Kousteni and her team also found that lipocalin 2 crosses the blood-brain barrier. In the brain, the protein binds to and activates melanocortin 4 receptor (MC4R) neurons in the hypothalamus, the primary brain region that regulates appetite. MC4R neurons are known to be involved in triggering appetite suppression.
"The hope is that lipocalin 2 might have the same effects in humans, and that our findings can be translated into the development of therapies for obesity and other metabolic disorders," said Dr. Kousteni.
Initial findings in humans are encouraging. In an analysis of patients with type 2 diabetes, the researchers found that blood levels of lipocalin 2 were inversely correlated with body weight and blood A1c levels, a long-term measure of blood sugar. "In other words, patients with higher lipocalin 2 levels had lower body weight and better glucose balance," said Dr. Kousteni.
Source: Eurekalert
Obesity Stops 'Guardian Immune Cells' from Doing Their Job
Special guardian immune cells are unable to function properly once obesity is established, which results in severe inflammation and metabolic dysfunction.
Advertisement
 Obesity, Weight Gain is a Risk Factor For 11 Types of CancerWeight gain was associated with risk of colorectal cancer and BMI with risk of gallbladder, gastric cardia, and ovarian cancers. | Advertisement
|
Advertisement
Recommended Readings
Latest Obesity News
KDS2010 drug was found to regulate astrocytes in brain which enhances fat metabolism resulting in weight loss without the need for dietary restrictions.
In obese patients undergoing weight-loss surgery, higher blood levels of inflammation are associated with poor weight loss post-surgery.
Coconut oil supplements over a long period of time may have a major impact on the metabolic changes in diet that can lead to obesity.
Intake of anti-obesity drug liraglutide, resulted in better brain activity and in-turn finer associative learning in obese individuals.
Anti-obesity potential of a tropical plant emerges as a promising solution to address the global surge in obesity-related lifestyle diseases.
